Bialik Medtech Israel

Company Overview

Snapshot

Founded in March 2026, Bialik Medtech Israel is in its pre-funding stage with 1–10 employees. The company is currently focused on developing an AI-assisted platform for continuous vital-sign monitoring.

Business overview

Bialik Medtech Israel is developing a continuous vital-sign monitoring platform designed for both human and veterinary care. The core technology involves medical hardware, a secure cloud environment, an AI-assisted software layer, and a companion smartphone app, enabling 24/7 tracking of metrics such as pulse, blood-oxygen saturation, and temperature. The company targets clinics and veterinary clinics through hardware and integration projects, with future plans for an app catering to individual users and animal owners, operating within the Health Tech & Life Sciences sector, specifically in Medical Devices and Medical Monitors.

Company Intelligence Q&A

What is Bialik Medtech Israel's primary focus?

Bialik Medtech Israel is focused on developing an AI-assisted platform for continuous human and veterinary vital-sign monitoring.

When was Bialik Medtech Israel founded?

Bialik Medtech Israel was founded in March 2026.

What markets does Bialik Medtech Israel target?

Bialik Medtech Israel targets clinics and veterinary clinics, and plans to offer an app for individual users and animal owners.

What technology underpins Bialik Medtech Israel's platform?

The platform integrates medical hardware, a secure cloud environment, an AI-assisted software layer, and a companion smartphone app for vital-sign tracking.

In which sector does Bialik Medtech Israel primarily operate?

Bialik Medtech Israel operates within the Health Tech & Life Sciences sector, with a focus on Medical Devices and Medical Monitors.